Clinical trial

PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer

NCT00816582

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

PROCEDURE · Unmapped registry intervention Diagnostic Imaging: 18F-FDG PET/CT Scan - Baseline Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Diagnostic Imaging: 18F-FES PET/CT - Baseline Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Diagnostic Imaging: 18F-FES PET/CT - 3 month follow-up Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer

Design: INTERVENTIONAL · Status: TERMINATED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2010-11-30

PhaseNA

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

Diagnostic Imaging: 18F-FDG PET/CT Scan - BaselinePROCEDURE

Diagnostic Imaging: 18F-FES PET/CT - BaselinePROCEDURE

Diagnostic Imaging: 18F-FES PET/CT - 3 month follow-upPROCEDURE

Sponsors & collaborators

British Columbia Cancer Agencylead sponsor

Mapped research locations

VancouverBritish Columbia, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00816582 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.